The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Ioerger, Thomas R ^a   Feng, Yicheng ^b   Chen, Xiaohua ^b   Dobos, Karen M ^c   Victor, Thomas C ^d   Streicher, Elizabeth M ^d   Warren, Robin M ^d   Gey van Pittius, Nicolaas C ^d   Van Helden, Paul D ^d   Sacchettini, James C ^b  

^a Texas AandM University   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PHYLOGENETIC TREE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; AMINO ACID SUBSTITUTION; CELL CLONE; CODON; DNA SEQUENCE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION; PHYLOGENY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

MYCOBACTERIUM TUBERCULOSIS;

AMINO ACID SUBSTITUTION; ANTITUBERCULAR AGENTS; CLONE CELLS; CODON; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOME, BACTERIAL; GENOTYPE; MUTAGENESIS, INSERTIONAL; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 78649321465     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-670     Document Type: Article

References (68)

1. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, Qing HZ, Enkhsaikan D, Nymadawa P, van Embden JD. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995, 33(12):3234-3238. 228679, 8586708.
2. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 2002, 10(1):45-52. 10.1016/S0966-842X(01)02277-6, 11755085.
3. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002, 8(8):843-849. 2732522, 12141971.
4. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 1997, 94(18):9869-9874. 10.1073/pnas.94.18.9869, 23284, 9275218.
5. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, Freedman VH, Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 2001, 98(10):5752-5757. 10.1073/pnas.091096998, 33285, 11320211.
6. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V, Barrera L, Kremer K, Hernandez-Pando R, Huygen K, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003, 133(1):30-37. 10.1046/j.1365-2249.2003.02171.x, 1808750, 12823275.
7. Manca C, Tsenova L, Barry CE, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999, 162(11):6740-6746.
8. Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, Reed MB, Mathema B, Barry CE, Kaplan G. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J Infect Dis 2005, 192(1):98-106. 10.1086/430614, 15942899.
9. Li Q, Whalen CC, Albert JM, Larkin R, Zukowski L, Cave MD, Silver RF. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun 2002, 70(11):6489-6493. 10.1128/IAI.70.11.6489-6493.2002, 130434, 12379735.
10. Zhang M, Gong J, Yang Z, Samten B, Cave MD, Barnes PF. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis 1999, 179(5):1213-1217. 10.1086/314738, 10191225.
11. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev A, Fedorin I. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005, 293(22):2726-2731. 10.1001/jama.293.22.2726, 15941801.
12. Borgdorff MW, Van Deutekom H, De Haas PE, Kremer K, Van Soolingen D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb) 2004, 84(5):337-340. 10.1016/j.tube.2003.10.002, 15207809.
13. Parwati I, Alisjahbana B, Apriani L, Soetikno RD, Ottenhoff TH, van der Zanden AG, van der Meer J, van Soolingen D, van Crevel R. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J Infect Dis 2010, 201(4):553-557. 10.1086/650311, 20064071.
14. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431(7004):84-87. 10.1038/nature02837, 15343336.
15. Constant P, Perez E, Malaga W, Laneelle MA, Saurel O, Daffe M, Guilhot C. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 2002, 277(41):38148-38158. 10.1074/jbc.M206538200, 12138124.
16. Glynn JR. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006, 12(5):736-743.
17. Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, Sharp V, Hewlett D, Brudney K, Alland D, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996, 276(15):1229-1235. 10.1001/jama.276.15.1229, 8849750.
18. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, Moghazeh SL, Eisner W, Daniel TM, Kaplan MH, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996, 275(6):452-457. 10.1001/jama.275.6.452, 8627966.
19. Pfyffer GE, Strassle A, van Gorkum T, Portaels F, Rigouts L, Mathieu C, Mirzoyev F, Traore H, van Embden JD. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 2001, 7(5):855-861. 10.3201/eid0705.010514, 2631864, 11747699.
20. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis 2008, 12(1):99-104.
21. Almeida D, Rodrigues C, Ashavaid TF, Lalvani A, Udwadia ZF, Mehta A. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 2005, 40(6):881-886. 10.1086/427940, 15736024.
22. Toungoussova OS, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol 2004, 42(3):281-290. 10.1016/j.femsim.2004.05.012, 15477041.
23. Park YK, Shin S, Ryu S, Cho SN, Koh WJ, Kwon OJ, Shim YS, Lew WJ, Bai GH. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 2005, 63(2):165-172. 10.1016/j.mimet.2005.03.002, 15893392.
24. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000, 6(3):302-305. 10.3201/eid0603.000312, 2640863, 10827122.
25. Iwamoto T, Yoshida S, Suzuki K, Wada T. Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. Antimicrob Agents Chemother 2008, 52(10):3805-3809. 10.1128/AAC.00579-08, 2565899, 18694954.
26. Hillemann D, Kubica T, Rusch-Gerdes S, Niemann S. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. Antimicrob Agents Chemother 2005, 49(3):1229-1231. 10.1128/AAC.49.3.1229-1231.2005, 549281, 15728936.
27. Johnson R, Warren RM, van der Spuy GD, Gey van Pittius NC, Theron D, Streicher EM, Bosman M, Coetzee GJ, van Helden PD, Victor TC. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis 2010, 14(1):119-121.
28. van der Spuy GD, Kremer K, Ndabambi SL, Beyers N, Dunbar R, Marais BJ, van Helden PD, Warren RM. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinb) 2009, 89(2):120-125. 10.1016/j.tube.2008.09.003, 19054717.
29. Streicher EM, Warren RM, Kewley C, Simpson J, Rastogi N, Sola C, van der Spuy GD, van Helden PD, Victor TC. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J Clin Microbiol 2004, 42(2):891-894. 10.1128/JCM.42.2.891-894.2004, 344460, 14766882.
30. Richardson M, van Lill SW, van der Spuy GD, Munch Z, Booysen CN, Beyers N, van Helden PD, Warren RM. Historic and recent events contribute to the disease dynamics of Beijing-like Mycobacterium tuberculosis isolates in a high incidence region. Int J Tuberc Lung Dis 2002, 6(11):1001-1011.
31. Warren R, Richardson M, van der Spuy G, Victor T, Sampson S, Beyers N, van Helden P. DNA fingerprinting and molecular epidemiology of tuberculosis: use and interpretation in an epidemic setting. Electrophoresis 1999, 20(8):1807-1812. 10.1002/(SICI)1522-2683(19990101)20:8<1807::AID-ELPS1807>3.0.CO;2-9, 10435453.
32. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJ. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 2006, 312(5782):1944-1946. 10.1126/science.1124410, 16809538.
33. Hanekom M, van der Spuy GD, Streicher E, Ndabambi SL, McEvoy CR, Kidd M, Beyers N, Victor TC, van Helden PD, Warren RM. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol 2007, 45(5):1483-1490. 10.1128/JCM.02191-06, 1865897, 17360841.
34. Mokrousov I, Jiao WW, Sun GZ, Liu JW, Valcheva V, Li M, Narvskaya O, Shen AD. Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype. Antimicrob Agents Chemother 2006, 50(8):2820-2823. 10.1128/AAC.00324-06, 1538659, 16870777.
35. Marais BJ, Victor TC, Hesseling AC, Barnard M, Jordaan A, Brittle W, Reuter H, Beyers N, van Helden PD, Warren RM, et al. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol 2006, 44(10):3539-3543. 10.1128/JCM.01291-06, 1594752, 16928967.
36. Middlebrook G, Cohn ML. Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health 1958, 48(7):844-853. 10.2105/AJPH.48.7.844, 1551698, 13545447.
37. Larsen MH, Biermann K, Tandberg S, Hsu T, Jacobs WR. Genetic Manipulation of Mycobacterium tuberculosis. Curr Protoc Microbiol 2007, Chapter 10(Unit 10A):12.
38. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35(4):907-914. 229700, 9157152.
39. Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, Salzberg SL. Versatile and open software for comparing large genomes. Genome Biol 2004, 5(2):R12. 10.1186/gb-2004-5-2-r12, 395750, 14759262.
40. Delcher AL, Phillippy A, Carlton J, Salzberg SL. Fast algorithms for large-scale genome alignment and comparison. Nucleic Acids Res 2002, 30(11):2478-2483. 10.1093/nar/30.11.2478, 117189, 12034836.
41. Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere YO, Kreiswirth BN, Van Soolingen D, Small PM. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 2005, 43(7):3185-3191. 10.1128/JCM.43.7.3185-3191.2005, 1169157, 16000433.
42. Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2003, 47(12):3799-3805. 10.1128/AAC.47.12.3799-3805.2003, 296216, 14638486.
43. DeBarber AE, Mdluli K, Bosman M, Bekker LG, Barry CE. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2000, 97(17):9677-9682. 10.1073/pnas.97.17.9677, 16924, 10944230.
44. Dessen A, Quemard A, Blanchard JS, Jacobs WR, Sacchettini JC. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 1995, 267(5204):1638-1641. 10.1126/science.7886450, 7886450.
45. Wang F, Langley R, Gulten G, Dover LG, Besra GS, Jacobs WR, Sacchettini JC. Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med 2007, 204(1):73-78. 10.1084/jem.20062100, 2118422, 17227913.
46. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998, 79(1):3-29. 10.1054/tuld.1998.0002, 10645439.
47. Strauss OJ, Warren RM, Jordaan A, Streicher EM, Hanekom M, Falmer AA, Albert H, Trollip A, Hoosain E, van Helden PD, et al. Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J Clin Microbiol 2008, 46(4):1514-1516. 10.1128/JCM.01938-07, 2292903, 18272712.
48. Sreevatsan S, Pan X, Stockbauer KE, Williams DL, Kreiswirth BN, Musser JM. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother 1996, 40(4):1024-1026. 163252, 8849220.
49. Via LE, Cho SN, Hwang S, Bang H, Park SK, Kang HS, Jeon D, Min SY, Oh T, Kim Y, et al. Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis. J Clin Microbiol 2010, 48(2):402-411. 10.1128/JCM.01476-09, 2815586, 20032248.
50. Suzuki Y, Katsukawa C, Tamaru A, Abe C, Makino M, Mizuguchi Y, Taniguchi H. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 1998, 36(5):1220-1225. 104803, 9574680.
51. Aubry A, Veziris N, Cambau E, Truffot-Pernot C, Jarlier V, Fisher LM. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob Agents Chemother 2006, 50(1):104-112. 10.1128/AAC.50.1.104-112.2006, 1346799, 16377674.
52. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR, Telenti A, Musser JM. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997, 41(8):1677-1681. 163984, 9257740.
53. Johnson R, Jordaan AM, Pretorius L, Engelke E, van der Spuy G, Kewley C, Bosman M, van Helden PD, Warren R, Victor TC. Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 2006, 10(1):68-73.
54. Sreevatsan S, Pan X, Zhang Y, Kreiswirth BN, Musser JM. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother 1997, 41(3):636-640. 163764, 9056006.
55. Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother 2000, 44(3):528-532. 10.1128/AAC.44.3.528-532.2000, 89721, 10681313.
56. Mphahlele M, Syre H, Valvatne H, Stavrum R, Mannsaker T, Muthivhi T, Weyer K, Fourie PB, Grewal HM. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol 2008, 46(10):3459-3464. 10.1128/JCM.00973-08, 2566105, 18753350.
57. Felsenstein J. PHYLIP (Phylogeny Inference Package) version 5.3c. 1993, Department of Genetics, University of Washington, Seattle.
58. Johnson R, Warren R, Strauss OJ, Jordaan AM, Falmer AA, Beyers N, Schaaf HS, Murray M, Cloete K, van Helden PD, et al. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis 2006, 10(12):1412-1414.
59. Warren RM, Victor TC, Streicher EM, Richardson M, van der Spuy GD, Johnson R, Chihota VN, Locht C, Supply P, van Helden PD. Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol 2004, 42(12):5774-5782. 10.1128/JCM.42.12.5774-5782.2004, 535222, 15583312.
60. Victor TC, Streicher EM, Kewley C, Jordaan AM, van der Spuy GD, Bosman M, Louw H, Murray M, Young D, van Helden PD, et al. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis 2007, 11(2):195-201.
61. Pillay M, Sturm AW. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis 2007, 45(11):1409-1414. 10.1086/522987, 17990220.
62. Ioerger TR, Koo S, No EG, Chen X, Larsen MH, Jacobs WR, Pillay M, Sturm AW, Sacchettini JC. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS One 2009, 4(11):e7778. 10.1371/journal.pone.0007778, 2767505, 19890396.
63. Parwati I, van Crevel R, van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 2010, 10(2):103-111. 10.1016/S1473-3099(09)70330-5, 20113979.
64. Ebrahimi-Rad M, Bifani P, Martin C, Kremer K, Samper S, Rauzier J, Kreiswirth B, Blazquez J, Jouan M, van Soolingen D, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 2003, 9(7):838-845.
65. Durbach SI, Springer B, Machowski EE, North RJ, Papavinasasundaram KG, Colston MJ, Bottger EC, Mizrahi V. DNA alkylation damage as a sensor of nitrosative stress in Mycobacterium tuberculosis. Infect Immun 2003, 71(2):997-1000. 10.1128/IAI.71.2.997-1000.2003, 145403, 12540583.
66. Dos Vultos T, Blazquez J, Rauzier J, Matic I, Gicquel B. Identification of Nudix hydrolase family members with an antimutator role in Mycobacterium tuberculosis and Mycobacterium smegmatis. J Bacteriol 2006, 188(8):3159-3161. 10.1128/JB.188.8.3159-3161.2006, 1446978, 16585780.
67. Werngren J, Hoffner SE. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J Clin Microbiol 2003, 41(4):1520-1524. 10.1128/JCM.41.4.1520-1524.2003, 153924, 12682139.
68. Calver AD, Falmer AA, Murray M, Strauss OJ, Streicher EM, Hanekom M, Liversage T, Masibi M, van Helden PD, Warren RM, et al. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg Infect Dis 2010, 16(2):264-271. 2958014, 20113557.